Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Chilcott J, Lloyd Jones M, Wilkinson A. Docetaxel for the adjuvant treatment of early breast cancer. Health Technology Assessment 2009; 13 (Suppl 1 Article 2) Indexing Status Subject indexing assigned by NLM MeSH Antineoplastic Combined Chemotherapy Protocols /economics /therapeutic use; Breast Neoplasms /drug therapy /economics /pathology; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Cyclophosphamide /administration & Doxorubicin /administration & Females; Lymphatic Metastasis; Neoplasm Recurrence, Local; Quality of Life; Randomized Controlled Trials as Topic; Taxoids /administration & Technology Assessment, Biomedical; dosage; dosage; dosage Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk AccessionNumber 32013000713 Date abstract record published 10/10/2013 |